About the Authors
- Stefan Balabanov
-
Affiliations Department of Oncology, Haematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald-Tumor Zentrum (UCCH), University Hospital Eppendorf (UKE), Hamburg, Germany, Division of Hematology, University Hospital Zürich, Zürich, Switzerland
- Thomas Wilhelm
-
Affiliations Department of Oncology, Haematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald-Tumor Zentrum (UCCH), University Hospital Eppendorf (UKE), Hamburg, Germany, Department of Biochemistry, University Hospital Aachen (UKA) of the Rheinisch.-Westfälische Technische Hochschule Aachen, Aachen, Germany
- Simone Venz
-
Affiliations Department of Medical Biochemistry and Molecular Biology, University of Greifswald, Greifswald, Germany, Interfacultary Institute of Genetics and Functional Genomics, University of Greifswald, Greifswald, Germany
- Gunhild Keller
-
Affiliation Department of Oncology, Haematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald-Tumor Zentrum (UCCH), University Hospital Eppendorf (UKE), Hamburg, Germany
- Christian Scharf
-
Affiliation Department of Otorhinolaryngology, Head and Neck Surgery, University of Greifswald, Greifswald, Germany
- Heike Pospisil
-
Affiliation Bioinformatics, University of Applied Sciences Wildau, Wildau, Germany
- Melanie Braig
-
Affiliation Department of Oncology, Haematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald-Tumor Zentrum (UCCH), University Hospital Eppendorf (UKE), Hamburg, Germany
- Christine Barett
-
Affiliation Department of Oncology, Haematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald-Tumor Zentrum (UCCH), University Hospital Eppendorf (UKE), Hamburg, Germany
- Carsten Bokemeyer
-
Affiliation Department of Oncology, Haematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald-Tumor Zentrum (UCCH), University Hospital Eppendorf (UKE), Hamburg, Germany
- Reinhard Walther
-
Affiliation Department of Medical Biochemistry and Molecular Biology, University of Greifswald, Greifswald, Germany
- Tim H. Brümmendorf
-
Contributed equally to this work with: Tim H. Brümmendorf, Andreas Schuppert
Affiliations Department of Oncology, Haematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald-Tumor Zentrum (UCCH), University Hospital Eppendorf (UKE), Hamburg, Germany, Medizinische Klinik IV - Hämatologie und Onkologie, Universitätsklinikum Aachen (UKA) of the Rheinisch.-Westfälische Technische Hochschule Aachen, Aachen, Germany
- Andreas Schuppert
-
Contributed equally to this work with: Tim H. Brümmendorf, Andreas Schuppert
* E-mail: schuppert@aices.rwth-aachen.de
Affiliation Aachen Institute for Advanced Study in Computational Engineering Science (AICES), RWTH Aachen University, Aachen, Germany
Competing Interests
THB received research support from Novartis and Bristol-Meyers Squibb. Furthermore THB participated in clinical trials investigating Imatinib, Nilotinib, Dasatinib and Danusertib in CML patients. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: SB AS THB. Performed the experiments: SB TW SV CS MB C. Barett AS. Analyzed the data: SB SV CS HP AS. Wrote the paper: SB GK MB C. Bokemeyer RW AS THB.